Literature DB >> 11955062

Role of T7 RNA polymerase His784 in start site selection and initial transcription.

Luis G Brieba1, Robert Padilla, Rui Sousa.   

Abstract

The role of steric constraints vs sequence preference in start site selection by T7 RNA polymerase was investigated by using a series of synthetic promoters in which the preferred template strand 'CC' initiation sequence was moved away from its normal position relative to the -17 to -6 element of the T7 promoter. It was found that the CC sequence directs efficient initiation if placed 1 or 2 nt downstream of its normal position, but not if placed upstream, or more than 2 nt downstream, of +1. Mutagenesis revealed that part of the bias to initiate with GTP is due to an interaction between histidine 784 and the 2-amino group of a guanosine bound in the initiating triphosphate position. This interaction is also important for holding short transcripts within the transcription complex during initial transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955062     DOI: 10.1021/bi016057v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  X-ray crystal structures elucidate the nucleotidyl transfer reaction of transcript initiation using two nucleotides.

Authors:  Michael L Gleghorn; Elena K Davydova; Ritwika Basu; Lucia B Rothman-Denes; Katsuhiko S Murakami
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

2.  Characterization of a T7-like lytic bacteriophage (phiSG-JL2) of Salmonella enterica serovar gallinarum biovar gallinarum.

Authors:  Hyuk-Joon Kwon; Sun-Hee Cho; Tae-Eun Kim; Yong-Jin Won; Jihye Jeong; Se Chang Park; Jae-Hong Kim; Han-Sang Yoo; Yong-Ho Park; Sun-Joong Kim
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

3.  A system for the continuous directed evolution of biomolecules.

Authors:  Kevin M Esvelt; Jacob C Carlson; David R Liu
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.